Pui Yee Ng

This inventor holds 79 USPTO granted patents and 12 published patent applications, plus 5 CIPO patents and 13 EPO patents, primarily in HDAC Inhibitors (CPC class C07D). Top assignees: Forma Therapeutics, Inc., Valo Health, Inc., Sirtris Pharmaceuticals, Inc.. Active years: 2008-2025.

USPTO Granted Patents = 79 (Patent Applications = 12)

% Patents Active = 79.7

CIPO Patents = 5 (Patent Applications = 6)

EPO Patents = 13 (Patent Applications = 24)

Average Co-Inventor Count = 7.8

ph-index = 16

Forward Citations = 972(Granted Patents)

Forward Citations (Not Self Cited) = 353(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Cambridge, MA (US) (2013 - 2014)
Boston, MA (US) (2008 - 2017)
Waltham, MA (US) (2017 - 2022)
Lexington, MA (US) (2020 - 2024)

Company Filing History:

35 out of 125

Forma Therapeutics, Inc.

Sirtris Pharmaceuticals, Inc.

patents

4. 10 out of 15

Valo Early Discovery, Inc.

H. Lee Moffitt Cancer Center and Research Institute, Inc.

patents

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

HDAC Inhibitors

Hydroxamic Acids

Ubiquitin-Specific Protease

Bicyclic Compounds

Carboxamides

Sirtuin Modulators

Alpha-Cinnamide

Spiror Indanes

Thienopyridine

Thienopyrazine

Amido Compounds

Aryl Compounds

79 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12479807 - METHODS USING HDAC11 INHIBITORS (2025-11-25),

2. 12304904 - Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors (2025-05-20),

3. 12264137 - 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2025-04-01),

4. 12213969 - 2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors (2025-02-04),

5. 12162888 - Carboxamides as ubiquitin-specific protease inhibitors (2024-12-10),

6. 11919839 - Alpha-cinnamide compounds and compositions as HDAC8 inhibitors (2024-03-05),

7. 11891365 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2024-02-06),

8. 11730721 - 2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors (2023-08-22),

9. 11702412 - Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors (2023-07-18),

10. 11535607 - Isoindolines as HDAC inhibitors (2022-12-27),

11. 11524966 - Carboxamides as ubiquitin-specific protease inhibitors (2022-12-13),

12. 11414392 - [6,6] fused bicyclic HDAC8 inhibitors (2022-08-16),

13. 11345672 - Methods using HDAC11 inhibitors (2022-05-31),

14. 11325917 - Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors (2022-05-10),

15. 11279681 - 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2022-03-22),

Title: The Innovative Journey of Inventor Pui Yee Ng

Introduction: Pui Yee Ng, a talented male inventor based in Waltham, MA (US), has made significant contributions to the field of innovations and inventions through his creative mind and dedication to technological advancements.

Latest Patents: Pui Yee Ng holds several patents in various technological domains, showcasing his versatility and expertise in inventing cutting-edge solutions to real-world problems.

Career Highlights: Throughout his career, Pui Yee Ng has demonstrated a keen eye for identifying gaps in the market and developing unique inventions to address them. His innovative spirit has led to the creation of groundbreaking technologies that have revolutionized industries.

Collaborations: Pui Yee Ng has collaborated with leading research institutions, universities, and companies to further his inventions and bring them to the market. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Pui Yee Ng's passion for innovation, coupled with his technical expertise, has established him as a prominent figure in the world of inventions. His relentless pursuit of excellence continues to inspire future generations of inventors to push the boundaries of what is possible.